Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

TIMI-IIA finds enoxaparin promising

July 1, 1997

New indication for enoxaparin recommended for approval

June 27, 1997

Thrombin inhibitors from Akzo Nobel

June 27, 1997

Orally active antithrombotic agents described by Pfizer

June 27, 1997

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

June 23, 1997

NicOx reveals antiinflammatory/antithrombotic compounds with low toxicity

June 20, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

June 17, 1997

Chimeric molecule shows promise as thrombolytic therapy

June 11, 1997

Thomae prepares fibrinogen receptor antagonists

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...